Literature DB >> 16569556

Restrictive physiology in cardiogenic shock: observations from echocardiography.

Harmony R Reynolds1, Sumeet K Anand, Justin M Fox, Shannon Harkness, Vladimir Dzavik, Harvey D White, John G Webb, Kenneth Gin, Judith S Hochman, Michael H Picard.   

Abstract

BACKGROUND: Left ventricular diastolic abnormalities are associated with adverse outcome in myocardial infarction. Intra-aortic balloon pump (IABP) support is associated with improved diastolic filling. In the SHOCK trial and registry, average left ventricular ejection fraction (LVEF) was approximately 30%, higher than expected based on the classic paradigm. We hypothesized that restrictive physiology plays a role in cardiogenic shock (CS).
METHODS: Echocardiograms obtained during the SHOCK trial within 24 hours of randomization were centrally interpreted. Patients with quantifiable mitral E-wave deceleration time were included (n = 64). The restrictive filling pattern was defined as deceleration time < 140 milliseconds.
RESULTS: The restrictive pattern was seen in 60.9% of patients studied. Patients with this pattern had lower LVEF (31.1% vs 39.0%, P = .02) and higher wall motion score index (2.1 vs 1.8, P = .05). Patients with restriction were more likely to have IABP support during echocardiography (73.7% vs 43.5%, P = .03). There was no difference with and without restriction in demographic and hemodynamic variables or in mitral regurgitation degree or extent of coronary disease. The restrictive pattern had positive predictive value of 80% for pulmonary capillary wedge pressure > or = 20 mm Hg. Thirty-day survival was 53.9% with restriction versus 68.0% without restriction, P = .31. There was no difference in New York Heart Association class at 1 year between groups.
CONCLUSIONS: The restrictive filling pattern is common in patients with CS, which may suggest that diastolic dysfunction contributes to CS pathogenesis. Patients with the restrictive pattern had lower LVEF despite IABP support. An association between the restrictive pattern and mortality was not demonstrated; power was limited by sample size.

Entities:  

Mesh:

Year:  2006        PMID: 16569556     DOI: 10.1016/j.ahj.2005.08.020

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

Review 1.  Management of refractory cardiogenic shock.

Authors:  Alex Reyentovich; Maya H Barghash; Judith S Hochman
Journal:  Nat Rev Cardiol       Date:  2016-06-30       Impact factor: 32.419

Review 2.  Evaluation and Management of ST-elevation Myocardial Infarction and Shock.

Authors:  Lee Chang; Robert Yeh
Journal:  Eur Cardiol       Date:  2014-12

3.  Opposite diastolic effects of omecamtiv mecarbil versus dobutamine and ivabradine co-treatment in pigs with acute ischemic heart failure.

Authors:  Leif Rønning; Jens P Bakkehaug; Lars Rødland; Anders B Kildal; Truls Myrmel; Ole-Jakob How
Journal:  Physiol Rep       Date:  2018-09

Review 4.  Management of cardiogenic shock complicating acute myocardial infarction: A review.

Authors:  Ashish H Shah; Rishi Puri; Ankur Kalra
Journal:  Clin Cardiol       Date:  2019-03-27       Impact factor: 2.882

5.  Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (-)-noradrenaline.

Authors:  Alexander Dashwood; Elizabeth Cheesman; Yee Weng Wong; Haris Haqqani; Nicole Beard; Karen Hay; Melanie Spratt; Wandy Chan; Peter Molenaar
Journal:  Pharmacol Res Perspect       Date:  2021-05

6.  Clinical utility of tissue Doppler imaging in patients with acute myocardial infarction complicated by cardiogenic shock.

Authors:  Adnan K Hameed; Tirath Gosal; Tielan Fang; Roien Ahmadie; Matthew Lytwyn; Ivan Barac; Shelley Zieroth; Farrukh Hussain; Davinder S Jassal
Journal:  Cardiovasc Ultrasound       Date:  2008-03-20       Impact factor: 2.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.